Katherine High
Director/Board Member at CRISPR THERAPEUTICS AG
Net worth: 2 M $ as of 2024-03-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Samarth Kulkarni | M | 45 | 9 years | |
| Herve Hoppenot | M | 64 | 10 years | |
| Pablo Cagnoni | M | 60 | 6 years | |
| Andrew Luber | M | - |
Virion Therapeutics LLC
 Virion Therapeutics LLC BiotechnologyHealth Technology Virion Therapeutics LLC develops chronic viral disease vaccines. It offers ChiVax and ChiVax-gD vaccines. The firm engages in developing immune-based treatments for virally-associated cancers and chronic viral infections. The company was founded by Bernard C. Rudnick, Hildegund C. J. Ertl and Andrew D. Luber in 2018 and is headquartered in Newark, DE. | 6 years |
| Steven Altschuler | M | 70 |
Innovative Genomics Institute
| 7 years |
| A. Betz | M | 77 |
The Children's Hospital of Philadelphia
 The Children's Hospital of Philadelphia Hospital/Nursing ManagementHealth Services The Children's Hospital of Philadelphia provides health care services. It specializes in pediatrics, research, fetal surgery, pediatric oncology, pediatric cardiology and cardiothoracic surgery, thoracic insufficiency syndrome, and pediatric airway disorders and transplants. The company was founded by Francis West Lewis in 1855 and is headquartered in Philadelphia, PA. | 13 years |
| Jennifer Doudna | M | 60 |
Innovative Genomics Institute
| 10 years |
| Ron Philip | M | - | 7 years | |
| Christopher Gheysens | M | 53 |
The Children's Hospital of Philadelphia
The Children's Hospital of Philadelphia Hospital/Nursing ManagementHealth Services The Children's Hospital of Philadelphia provides health care services. It specializes in pediatrics, research, fetal surgery, pediatric oncology, pediatric cardiology and cardiothoracic surgery, thoracic insufficiency syndrome, and pediatric airway disorders and transplants. The company was founded by Francis West Lewis in 1855 and is headquartered in Philadelphia, PA. | 10 years |
| Jonathan Terrett | M | - | 7 years | |
| Jim Kasinger | M | 52 | 7 years | |
| Susanne Antonie Schaffert | M | 57 | 2 years | |
| Julian Baker | M | 57 | 23 years | |
| Edmund Harrigan | M | 71 | 5 years | |
| Ali Behbahani | M | 47 | 9 years | |
| Raju Prasad | M | 40 | 1 years | |
| Harold Edward Fleming | M | 61 | 3 years | |
| Jennifer Flaisher | F | - | 7 years | |
| Thomas Tray | M | 46 | 19 years | |
| John Greene | M | 58 | 5 years | |
| Maria Fardis | M | 56 | 2 years | |
| Sheila Denton | F | 58 | 1 years | |
| Otis Brawley | M | 64 | 3 years | |
| Simeon George | M | 46 | 9 years | |
| Paul Clancy | M | 62 | 9 years | |
| Jacqualyn Fouse | M | 62 | 7 years | |
| Doug Treco Treco | M | 66 | 4 years | |
| Jean-Jacques Bienaimé | M | 70 | 9 years | |
| Edward Penhoet | M | 83 |
Innovative Genomics Institute
| - |
| Susan Kim | F | - | - | |
| Barry Flannelly | M | 66 | 10 years | |
| Christiana Stamoulis | F | 53 | 5 years | |
| M. Berrey | M | 57 |
Virion Therapeutics LLC
Virion Therapeutics LLC BiotechnologyHealth Technology Virion Therapeutics LLC develops chronic viral disease vaccines. It offers ChiVax and ChiVax-gD vaccines. The firm engages in developing immune-based treatments for virally-associated cancers and chronic viral infections. The company was founded by Bernard C. Rudnick, Hildegund C. J. Ertl and Andrew D. Luber in 2018 and is headquartered in Newark, DE. | 3 years |
| Williamson Z. Bradford | M | 62 |
Virion Therapeutics LLC
Virion Therapeutics LLC BiotechnologyHealth Technology Virion Therapeutics LLC develops chronic viral disease vaccines. It offers ChiVax and ChiVax-gD vaccines. The firm engages in developing immune-based treatments for virally-associated cancers and chronic viral infections. The company was founded by Bernard C. Rudnick, Hildegund C. J. Ertl and Andrew D. Luber in 2018 and is headquartered in Newark, DE. | 3 years |
| Sue Currie | M | - |
Virion Therapeutics LLC
Virion Therapeutics LLC BiotechnologyHealth Technology Virion Therapeutics LLC develops chronic viral disease vaccines. It offers ChiVax and ChiVax-gD vaccines. The firm engages in developing immune-based treatments for virally-associated cancers and chronic viral infections. The company was founded by Bernard C. Rudnick, Hildegund C. J. Ertl and Andrew D. Luber in 2018 and is headquartered in Newark, DE. | 3 years |
| Peter Langmuir | M | - | 9 years | |
| Rachel Eides | F | - | - | |
| Denise Brashear | F | - | 2 years | |
| Brad Ringeisen | M | - |
Innovative Genomics Institute
| 4 years |
| Reed Jobs | M | - |
Innovative Genomics Institute
| - |
| Daniel Lowenstein | M | - |
Innovative Genomics Institute
| - |
| Mike Botchan | M | - |
Innovative Genomics Institute
| - |
| Hildegund C. J. Ertl | M | - |
Virion Therapeutics LLC
Virion Therapeutics LLC BiotechnologyHealth Technology Virion Therapeutics LLC develops chronic viral disease vaccines. It offers ChiVax and ChiVax-gD vaccines. The firm engages in developing immune-based treatments for virally-associated cancers and chronic viral infections. The company was founded by Bernard C. Rudnick, Hildegund C. J. Ertl and Andrew D. Luber in 2018 and is headquartered in Newark, DE. | 6 years |
| Benjamin J. Strain | M | - | 1 years | |
| Alex Harding | M | - | 1 years | |
| Federico Mingozzi | M | 50 | 7 years | |
| Michael Morrissey | M | - | 8 years | |
| Robert Tjian | M | 74 |
Innovative Genomics Institute
| - |
| Catalina Loveman | F | - | 9 years | |
| Megan Wherry Menner | F | - | 8 years | |
| Steven Stein | M | 57 | 9 years | |
| Thomas Penn | M | 78 |
Virion Therapeutics LLC
Virion Therapeutics LLC BiotechnologyHealth Technology Virion Therapeutics LLC develops chronic viral disease vaccines. It offers ChiVax and ChiVax-gD vaccines. The firm engages in developing immune-based treatments for virally-associated cancers and chronic viral infections. The company was founded by Bernard C. Rudnick, Hildegund C. J. Ertl and Andrew D. Luber in 2018 and is headquartered in Newark, DE. | - |
| Keith Mikkelson | M | - | 22 years | |
| Rifat Pamukcu | M | 66 |
Virion Therapeutics LLC
Virion Therapeutics LLC BiotechnologyHealth Technology Virion Therapeutics LLC develops chronic viral disease vaccines. It offers ChiVax and ChiVax-gD vaccines. The firm engages in developing immune-based treatments for virally-associated cancers and chronic viral infections. The company was founded by Bernard C. Rudnick, Hildegund C. J. Ertl and Andrew D. Luber in 2018 and is headquartered in Newark, DE. | 6 years |
| Paula Swain | F | 66 | 22 years | |
| Bruce Resnick | M | - | 5 years | |
| Stephen Kennedy | M | 67 | 5 years | |
| Lothar H. Finke | M | - | 7 years | |
| Sean Johnston | M | - | 5 years | |
| Vijay Iyengar | M | 51 | 8 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Rodger Novak | M | 56 | 10 years | |
| Paul Friedman | M | 81 | 20 years | |
| Rogério Vivaldi Coelho | M | 60 | 2 years | |
| Bradley Bolzon | M | 64 | 9 years | |
| Jeffrey D. Marrazzo | M | 46 | 9 years | |
| Thomas Woiwode | M | 52 | 5 years | |
| Maria Pasquale | F | 58 | 5 years | |
| Paul Trower | M | 54 | 18 years | |
| Jennifer A. Wellman | F | 46 | - | |
| J. Fraser Wright | M | 66 | - | |
| Michael Tomsicek | M | 58 | 4 years | |
| Wendy Dixon | M | 68 | 12 years | |
| Joseph W. la Barge | M | 53 | 8 years | |
| Charles Sigal | M | 72 | 5 years | |
| Anand Mehra | M | 48 | 5 years | |
| Kurt von Emster | M | 56 | 4 years | |
| Robert Perez | M | 59 | 1 years | |
| Lota Zoth | F | 64 | 3 years | |
| Paul Brooke | M | 77 | 19 years | |
| Vin Milano Milano | M | 60 | 5 years | |
| Michael Charles A. Booth | M | 53 | 7 years | |
| Lars Ekman | M | 74 | 5 years | |
| Stephen Webster | M | 63 | 5 years | |
| Tony Ho | M | 58 | 4 years | |
| Amy Garabedian | F | - | 5 years | |
| Michael Purvis | M | - | 6 years | |
| Brendan Smith | M | 48 | 2 years | |
| Ramzi Benamar | M | 51 | 3 years | |
| Thomas Ciulla | M | 59 | 1 years | |
| John Furey | M | 59 | 2 years | |
| Daniel Faga | M | 44 | 3 years | |
| Beverly L. Davidson | M | - | - | |
| W. Richey Neuman | M | - |
Perelman School of Medicine
| 8 years |
| Monique da Silva | F | - | 4 years | |
| Daniel Skovronsky | M | 50 |
Perelman School of Medicine
| 3 years |
| Lorence Kim | M | 49 |
Perelman School of Medicine
| 3 years |
| Ryan Asay | M | - | 3 years | |
| Abhinav Shukla | M | 51 | - | |
| Phuong Khanh Morrow | M | 50 | 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 75 | 75.76% |
| Switzerland | 25 | 25.25% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Katherine High
- Personal Network
